Yiqing Zhou

Title: Yiqing Zhou: Innovator in Cancer Treatment

Introduction

Yiqing Zhou is a prominent inventor based in Lafayette, CA (US). She has made significant contributions to the field of cancer treatment, particularly in the development of innovative methods for addressing multiple myeloma and other cancers. With a total of 2 patents, her work is paving the way for new therapeutic approaches.

Latest Patents

Yiqing Zhou's latest patents include a method of treating multiple myeloma using 17-AAG or 17-AG, or a prodrug of either. This method involves administering 17-allylamino-17-demethoxy-geldanamycin or 17-amino geldanamycin to the subject. Another notable patent is for a method for treating diseases using HSP90-inhibiting agents in combination with antimitotics. This invention provides a synergistic effect by administering an HSP90 inhibitor and an antimitotic, either sequentially or in combination, to treat cancer effectively.

Career Highlights

Yiqing Zhou is currently associated with Kosan Biosciences Incorporated, where she continues to advance her research and innovations in cancer therapies. Her work is characterized by a commitment to improving treatment outcomes for patients suffering from various forms of cancer.

Collaborations

Yiqing has collaborated with notable colleagues, including Robert G Johnson, Jr. and Thomas Müller, to further enhance her research efforts and contribute to the scientific community.

Conclusion

Yiqing Zhou's innovative approaches to cancer treatment exemplify her dedication to improving patient care through scientific research. Her patents reflect a significant advancement in the field, showcasing her role as a leading inventor in oncology.